Nicole R. Dobson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nicole R. Dobson has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Carl E. Hunt
Department of Pediatrics Uniformed Services University of the Health Sciences Bethesda Maryland USA
6 shared publicationsCara H. Olsen
Biostatistics Consulting Center Uniformed Services University of the Health Sciences Bethesda Maryland USA
4 shared publicationsAnwar E. Ahmed
Biostatistics Consulting Center Uniformed Services University of the Health Sciences Bethesda Maryland USA
2 shared publicationsDevon Kuehn
Department of Pediatrics, East Carolina University, Greenville, NC, United States
2 shared publications- Katrina A. Savioli
Department of Pediatrics Uniformed Services University of the Health Sciences Bethesda Maryland USA
2 shared publications - Reese Hunter Clark
Center for Research, Education, Quality and Safety, Pediatrix Medical Group, Sunrise, FL, USA
2 shared publications
Latest Publications
- 6 July 2025
- Published by Wiley in Journal of Parenteral and Enteral Nutrition
- Vol. 49 (7) , 846-854
Association between late parenteral nutrition initiation and length of hospital stay in late preterm and term infants: A retrospective cohort study
Background: We aimed to determine the association between timing of parenteral nutrition initiation and length of hospital stay in late preterm and term infants.Methods: This retrospective cohort study includes infants ≥35 weeks gestation admitted to a Pediatrix Medical Group neonatal intensive care unit in 2009–2019. Propensity score matching was used to control for demographics, delivery characteristics, and severity of illness. The primary outcome was length of hospital stay. Secondary outcomes were duration of mechanical ventilation, late‐onset sepsis, and mortality. Early parenteral nutrition was defined as initiation on the day of birth and late as initiation after.Results: The total cohort has 475,708 infants; of 259,495 eligible infants, 97,577 (37.6%) received parenteral nutrition. After propensity score matching, outcomes were analyzed for 13,712 infants. Infants receiving late parenteral nutrition (n = 6856) have no difference in length of hospital stay compared with early. Analysis of secondary outcomes reveals no differences between groups. Negative binomial regression shows decreased length of hospital stay when parenteral nutrition is initiated on days of life 1–3 compared with day of birth or days 4–10.Conclusion: Initiating parenteral nutrition on day 1 or later vs day of birth is not associated with increased length of hospital stay in late preterm and term infants. Exploratory analysis suggests that initiation of parenteral nutrition on days 1–3 instead of day of birth or days 4–10 is associated with decreased hospital stay. Prospective clinical trials are needed to better understand optimal timing of parenteral nutrition in this population.
- 6 July 2025
- Published by Wiley in Journal of Parenteral and Enteral Nutrition
- Vol. 49 (7) , 846-854
Association between late parenteral nutrition initiation and length of hospital stay in late preterm and term infants: A retrospective cohort study
Background: We aimed to determine the association between timing of parenteral nutrition initiation and length of hospital stay in late preterm and term infants.Methods: This retrospective cohort study includes infants ≥35 weeks gestation admitted to a Pediatrix Medical Group neonatal intensive care unit in 2009–2019. Propensity score matching was used to control for demographics, delivery characteristics, and severity of illness. The primary outcome was length of hospital stay. Secondary outcomes were duration of mechanical ventilation, late‐onset sepsis, and mortality. Early parenteral nutrition was defined as initiation on the day of birth and late as initiation after.Results: The total cohort has 475,708 infants; of 259,495 eligible infants, 97,577 (37.6%) received parenteral nutrition. After propensity score matching, outcomes were analyzed for 13,712 infants. Infants receiving late parenteral nutrition (n = 6856) have no difference in length of hospital stay compared with early. Analysis of secondary outcomes reveals no differences between groups. Negative binomial regression shows decreased length of hospital stay when parenteral nutrition is initiated on days of life 1–3 compared with day of birth or days 4–10.Conclusion: Initiating parenteral nutrition on day 1 or later vs day of birth is not associated with increased length of hospital stay in late preterm and term infants. Exploratory analysis suggests that initiation of parenteral nutrition on days 1–3 instead of day of birth or days 4–10 is associated with decreased hospital stay. Prospective clinical trials are needed to better understand optimal timing of parenteral nutrition in this population.
- 6 June 2025
- Published by Wiley in Journal of Parenteral and Enteral Nutrition
- Vol. 49 (7) , 837-845
Association between parenteral nutrition and length of stay in late preterm and term infants: A retrospective cohort study
Background: We aimed to determine how the use of parenteral nutrition in late preterm and term infants admitted to the neonatal intensive care unit (NICU) affects outcomes, specifically length of stay.Methods: This is a retrospective cohort study that included infants ≥35 weeks gestation admitted to a Pediatrix Medical Group–affiliated NICU on day of life 0–2 in 2009–2019. Propensity score matching was used to control for demographics, delivery characteristics, and severity of illness. Infants were excluded if they received comfort or palliative care in the delivery room or transferred before discharge home. The primary outcome was length of stay. Secondary outcomes were duration of conventional and high‐frequency ventilation, late‐onset sepsis, and mortality.Results: The total cohort had 470,433 neonates; of the 259,495 infants who met inclusion criteria and survived to discharge, 97,577 (37.6%) received parenteral nutrition. Of 59,580 propensity‐matched neonates comparing parenteral nutrition vs no parenteral nutrition, those receiving parenteral nutrition (n = 29,790) had a longer median length of stay (10 vs 9 days, P < 0.0001). Analysis of secondary outcomes revealed a higher mean number of conventional ventilation days, higher odds of late‐onset sepsis, and higher odds of mortality in neonates receiving parenteral nutrition vs no parenteral nutrition.Conclusion: Parenteral nutrition in late preterm and term neonates is associated with increased length of stay, duration of conventional ventilation, and odds of late‐onset sepsis and mortality. Prospective clinical trials are needed to better understand the optimal use and timing of parenteral nutrition and associated morbidities in this population.
- 6 June 2025
- Published by Wiley in Journal of Parenteral and Enteral Nutrition
- Vol. 49 (7) , 837-845
Association between parenteral nutrition and length of stay in late preterm and term infants: A retrospective cohort study
Background: We aimed to determine how the use of parenteral nutrition in late preterm and term infants admitted to the neonatal intensive care unit (NICU) affects outcomes, specifically length of stay.Methods: This is a retrospective cohort study that included infants ≥35 weeks gestation admitted to a Pediatrix Medical Group–affiliated NICU on day of life 0–2 in 2009–2019. Propensity score matching was used to control for demographics, delivery characteristics, and severity of illness. Infants were excluded if they received comfort or palliative care in the delivery room or transferred before discharge home. The primary outcome was length of stay. Secondary outcomes were duration of conventional and high‐frequency ventilation, late‐onset sepsis, and mortality.Results: The total cohort had 470,433 neonates; of the 259,495 infants who met inclusion criteria and survived to discharge, 97,577 (37.6%) received parenteral nutrition. Of 59,580 propensity‐matched neonates comparing parenteral nutrition vs no parenteral nutrition, those receiving parenteral nutrition (n = 29,790) had a longer median length of stay (10 vs 9 days, P < 0.0001). Analysis of secondary outcomes revealed a higher mean number of conventional ventilation days, higher odds of late‐onset sepsis, and higher odds of mortality in neonates receiving parenteral nutrition vs no parenteral nutrition.Conclusion: Parenteral nutrition in late preterm and term neonates is associated with increased length of stay, duration of conventional ventilation, and odds of late‐onset sepsis and mortality. Prospective clinical trials are needed to better understand the optimal use and timing of parenteral nutrition and associated morbidities in this population.
- 12 March 2021
- Published by Springer Nature in Journal of Perinatology
- Vol. 41 (9) , 2111-2123
Immature control of breathing and apnea of prematurity: the known and unknown
This narrative review provides a broad perspective on immature control of breathing, which is universal in infants born premature. The degree of immaturity and severity of clinical symptoms are inversely correlated with gestational age. This immaturity presents as prolonged apneas with associated bradycardia or desaturation, or brief respiratory pauses, periodic breathing, and intermittent hypoxia. These manifestations are encompassed within the clinical diagnosis of apnea of prematurity, but there is no consensus on minimum criteria required for diagnosis. Common treatment strategies include caffeine and noninvasive respiratory support, but other therapies have also been advocated with varying effectiveness. There is considerable variability in when and how to initiate and discontinue treatment. There are significant knowledge gaps regarding effective strategies to quantify the severity of clinical manifestations of immature breathing, which prevent us from better understanding the long-term potential adverse outcomes, including neurodevelopment and sudden unexpected infant death.
- 12 March 2021
- Published by Springer Nature in Journal of Perinatology
- Vol. 41 (9) , 2111-2123
Immature control of breathing and apnea of prematurity: the known and unknown
This narrative review provides a broad perspective on immature control of breathing, which is universal in infants born premature. The degree of immaturity and severity of clinical symptoms are inversely correlated with gestational age. This immaturity presents as prolonged apneas with associated bradycardia or desaturation, or brief respiratory pauses, periodic breathing, and intermittent hypoxia. These manifestations are encompassed within the clinical diagnosis of apnea of prematurity, but there is no consensus on minimum criteria required for diagnosis. Common treatment strategies include caffeine and noninvasive respiratory support, but other therapies have also been advocated with varying effectiveness. There is considerable variability in when and how to initiate and discontinue treatment. There are significant knowledge gaps regarding effective strategies to quantify the severity of clinical manifestations of immature breathing, which prevent us from better understanding the long-term potential adverse outcomes, including neurodevelopment and sudden unexpected infant death.
- 23 November 2019
- Published by SAGE Publications in Journal of Neonatal-Perinatal Medicine
- Vol. 13 (2) , 223-230
Longitudinal growth changes from birth to 8–9 years in preterm and full term births
BACKGROUND: The aim of this study is to assess the effect of age at adiposity rebound (AR) and changes in growth between birth and 6 months on growth status at 8–9 years in children born term and preterm. Age at AR is inversely correlated with risk for later obesity in children born full term, but has not been analyzed in children born preterm. METHODS: Birth anthropometrics, and weight and length/height data from age 6 months through 8–9 years were recorded for 175 children born in 2008 in the military health system. Calculated variables include body mass index (BMI, kg/m2), Z-scores, and age at AR. Results: Age at AR could be calculated for 150 children (32% preterm); average age was 5.4 years and 5.3 years for children born term and preterm, respectively (NS). For children born term and preterm, there was a significant correlation between younger age at AR and higher BMI Z-score at 8–9 years ( r = – 0.685), and a direct relationship between weight Z-score change from birth to 6 months and weight Z-scores at 8–9 years ( p = 0.034). CONCLUSIONS: Younger age at AR correlates with higher BMI Z-score at 8–9 years in children born both term and preterm. Weight gain from birth to 6 months correlates with weight Z-score at 8–9 years. These results emphasize the importance of younger age at AR in addition to greater early weight gain as an indicator of later obesity.
- 23 November 2019
- Published by SAGE Publications in Journal of Neonatal-Perinatal Medicine
- Vol. 13 (2) , 223-230
Longitudinal growth changes from birth to 8–9 years in preterm and full term births
BACKGROUND: The aim of this study is to assess the effect of age at adiposity rebound (AR) and changes in growth between birth and 6 months on growth status at 8–9 years in children born term and preterm. Age at AR is inversely correlated with risk for later obesity in children born full term, but has not been analyzed in children born preterm. METHODS: Birth anthropometrics, and weight and length/height data from age 6 months through 8–9 years were recorded for 175 children born in 2008 in the military health system. Calculated variables include body mass index (BMI, kg/m2), Z-scores, and age at AR. Results: Age at AR could be calculated for 150 children (32% preterm); average age was 5.4 years and 5.3 years for children born term and preterm, respectively (NS). For children born term and preterm, there was a significant correlation between younger age at AR and higher BMI Z-score at 8–9 years ( r = – 0.685), and a direct relationship between weight Z-score change from birth to 6 months and weight Z-scores at 8–9 years ( p = 0.034). CONCLUSIONS: Younger age at AR correlates with higher BMI Z-score at 8–9 years in children born both term and preterm. Weight gain from birth to 6 months correlates with weight Z-score at 8–9 years. These results emphasize the importance of younger age at AR in addition to greater early weight gain as an indicator of later obesity.
- 1 August 2019
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 144 (2_MeetingA) , 905
Longitudinal Changes in Growth in Children Born Preterm and Full Term from Birth to 8-9 Years of Age
- 1 August 2019
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 144 (2_MeetingA) , 905
Longitudinal Changes in Growth in Children Born Preterm and Full Term from Birth to 8-9 Years of Age
- 9 July 2018
- Published by Springer Nature in Pediatric Research
- Vol. 84 (3) , 333-340
Caffeine: an evidence-based success story in VLBW pharmacotherapy
Apnea of prematurity (AOP) is a common and pervasive problem in very low birth weight infants. Methylxanthines were reported >40 years ago to be an effective therapy and, by the early 2000s, caffeine had become the preferred methylxanthine because of its wide therapeutic index, excellent bioavailability, and longer half-life. A clinical trial to address unresolved questions and toxicity concerns, completed in 2004, confirmed significant benefits of caffeine therapy, including shorter duration of intubation and respiratory support, reduced incidence of chronic lung disease, decreased need for treatment of patent ductus arteriosus, reduced severity of retinopathy of prematurity, and improved motor and visual function. Cohort studies have now further delineated the benefits of initiation of therapy before 3 days postnatal age, and of higher maintenance doses to achieve incremental beneficial effects. This review summarizes the pivotal and in particular the most recent studies that have established the safety and efficacy of caffeine therapy for AOP and other respiratory and neurodevelopmental outcomes. Caffeine has a very favorable benefit-to-risk ratio, and has become one of the most prescribed and cost-effective pharmacotherapies in the NICU.
- 9 July 2018
- Published by Springer Nature in Pediatric Research
- Vol. 84 (3) , 333-340
Caffeine: an evidence-based success story in VLBW pharmacotherapy
Apnea of prematurity (AOP) is a common and pervasive problem in very low birth weight infants. Methylxanthines were reported >40 years ago to be an effective therapy and, by the early 2000s, caffeine had become the preferred methylxanthine because of its wide therapeutic index, excellent bioavailability, and longer half-life. A clinical trial to address unresolved questions and toxicity concerns, completed in 2004, confirmed significant benefits of caffeine therapy, including shorter duration of intubation and respiratory support, reduced incidence of chronic lung disease, decreased need for treatment of patent ductus arteriosus, reduced severity of retinopathy of prematurity, and improved motor and visual function. Cohort studies have now further delineated the benefits of initiation of therapy before 3 days postnatal age, and of higher maintenance doses to achieve incremental beneficial effects. This review summarizes the pivotal and in particular the most recent studies that have established the safety and efficacy of caffeine therapy for AOP and other respiratory and neurodevelopmental outcomes. Caffeine has a very favorable benefit-to-risk ratio, and has become one of the most prescribed and cost-effective pharmacotherapies in the NICU.
- 1 January 2008
- Published by American Academy of Pediatrics (AAP) in NeoReviews
- Vol. 9 (1) , e39-e41
Index of suspicion in the nursery
- 1 January 2008
- Published by American Academy of Pediatrics (AAP) in NeoReviews
- Vol. 9 (1) , e39-e41
Index of suspicion in the nursery